Dyne Therapeutics, INC. (DYN) SEC Filings — 2025
16 SEC filings for Dyne Therapeutics, INC. (DYN) in 2025.
Filings
- Dyne Therapeutics Announces Executive and Director Changes — 8-K · Dec 23, 2025
- Dyne Therapeutics Files 8-K with Material Agreement — 8-K · Dec 10, 2025
- Dyne Therapeutics, INC. 8-K Filing — 8-K · Dec 8, 2025
- Dyne's Q3 Loss Widens on Soaring R&D, Bolsters Cash with Offerings — 10-Q · Nov 5, 2025
- Dyne Therapeutics Reports Officer and Director Changes — 8-K · Oct 2, 2025
- Dyne Therapeutics Files 8-K — 8-K · Aug 4, 2025
- Dyne's Net Loss Widens to $145.8M Amid R&D Ramp-Up — 10-Q · Jul 28, 2025
- Dyne Therapeutics Files 8-K with Material Agreement Details — 8-K · Jul 1, 2025
- Dyne Therapeutics Enters Material Definitive Agreement — 8-K · Jun 30, 2025
- Dyne Therapeutics Files 8-K for Regulatory Updates — 8-K · Jun 17, 2025
- Dyne Therapeutics Files 8-K on Security Holder Votes — 8-K · Jun 5, 2025
- Dyne Therapeutics Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Dyne Therapeutics Executive Compensation Revealed — DEF 14A · Apr 15, 2025
- Dyne Therapeutics Files 8-K on Officer/Director Changes — 8-K · Mar 20, 2025
- Dyne Therapeutics Files 2024 10-K — 10-K · Feb 27, 2025
- Dyne Therapeutics Files Current Report — 8-K · Jan 10, 2025